Candida glabrata Vaginal Infection: When Recurrent Thrush Doesn’t Respond to Standard Treatment

If you’ve treated thrush with an over-the-counter cream or tablet and symptoms are still there, it’s important not to assume the treatment simply wasn’t strong enough. There are a number of different species of Candida - the yeast that causes thrush - and not all of them respond the same way to treatment.

While Candida albicans is the most common cause of vulvovaginal candidiasis (or thrush) and usually responds to azole antifungals such as fluconazole or clotrimazole, another species — Candida glabrata — behaves differently. It is inherently less sensitive to azole therapy and can persist despite appropriate standard treatment.

When symptoms don’t resolve, repeating the same medication is unlikely to change the outcome. The first step should be accurate diagnosis via a high vaginal swab with microscopy and culture.

How Candida glabrata differs from Candida albicans

Candida glabrata differs from C. albicans in several clinically relevant ways. It does not form the same hyphal structures that make C. albicans easier to identify under a microscope. It can be more difficult to detect and may require specific culture techniques. It also forms biofilms more readily, which help it to resist antifungal medications and contribute to it's persistence. This is why standard single-dose fluconazole often fails.

Medical Treatment Guidelines in Australia

According to RACGP treatment guidance for the management of recurrent thrush, when Candida glabrata is identified and azole therapy has failed, alternative treatments should be considered.

One commonly recommended option is boric acid vaginal pessaries, typically compounded by a pharmacy and prescribed by a GP. Boric acid acts via a different mechanism to azoles and is often effective in cases of azole-resistant infection. It is essential that boric acid is used under medical supervision and not ingested. Treatment decisions should always be individualised and coordinated with your GP, particularly in cases of recurrent infection.

However, eradication alone is rarely the whole story.

Why recurrence happens

When infections keep returning, the question shifts from how do we clear it? to why is the environment allowing it to recur?

The vaginal ecosystem is not sterile. It is a dynamic microbial community influenced by hormones, immune function, metabolic health and external exposures. A healthy vaginal microbiome is typically (but not always) dominated by Lactobacillus species, which help maintain an acidic pH (around 3.5–4.5). This acidic environment inhibits the overgrowth of pathogenic organisms, including Candida species. Lactobacilli protect through several mechanisms:

• Production of lactic acid, maintaining low vaginal pH

• Production of hydrogen peroxide and bacteriocins

• Competitive exclusion of pathogens

• Modulation of local immune signalling

When Lactobacillus dominance is reduced, vaginal pH may rise and colonisation resistance weakens, making overgrowth more likely.

Vaginal microbiome community state types (CSTs)

Research has identified several vaginal microbiome community state types (CSTs).

CST I, II, III and V are dominated by different Lactobacillus species and are generally considered protective. CST IV, in contrast, is characterised by lower Lactobacillus abundance and greater microbial diversity. While diversity is usually positive in the gut, in the vagina it is often associated with higher pH, inflammation and increased susceptibility to infection.

This is why simply taking a probiotic is not always sufficient. The goal is not random supplementation. It is restoration of Lactobacillus dominance within a broader ecological context.

Factors that influence vaginal microbiome stability

The vaginal microbiome does not exist in isolation.

➡️ Hormonal patterns

Oestrogen promotes glycogen deposition in vaginal epithelial cells. Glycogen is metabolised into substrates that support Lactobacillus growth. Low oestrogen states, including perimenopause, postpartum, or certain contraceptives can reduce glycogen availability and alter microbial balance.

➡️ Immune regulation

Local mucosal immunity plays a key role in controlling fungal overgrowth. Chronic stress, sleep deprivation, systemic inflammation and immune suppression can impair this regulation.

➡️ Metabolic health

Poor glycaemic control can increase glucose availability in vaginal secretions, creating an environment more favourable to yeast proliferation.

➡️ Antibiotic exposure

Broad-spectrum antibiotics reduce bacterial populations, including protective Lactobacillus species, allowing Candida overgrowth.

➡️ Partner factors

Sexual activity can influence the vaginal microbiome through pH changes and microbial exchange. While Candida is not strictly classified as an STI, partner-related factors can influence recurrence patterns in some cases.

Beyond suppression

Clearing Candida glabrata with appropriate medication treatment is often necessary. But when infections are recurrent, long-term stability depends on restoring the conditions that support microbial balance. This may include:

• Supporting Lactobacillus dominance

• Addressing metabolic contributors

• Reviewing hormonal context

• Improving sleep and stress regulation

• Considering mucosal integrity

The aim is not simply eradication of the Candida organisms. It's to build resilience in the vaginal ecosystem to protect against infections in the future.

When to seek further evaluation

If symptoms persist despite treatment, or if infections recur frequently, further investigation is warranted. This may include repeat cultures, assessment of blood glucose regulation, and review of contributing medications or hormonal factors. We can even sequence your vaginal microbiome to get an understanding of what's driving the recurrence.

Recurrent vulvovaginal candidiasis is common and treatable, but it requires accurate diagnosis and a structured approach. Persistent thrush is not a reflection of hygiene or personal failure. It is a signal that the microbial ecosystem requires attention.

If you are dealing with recurrent vaginal infections and feel caught in cycles of temporary relief and recurrence, I’ve written further about the role of the vaginal microbiome in prevention and long-term management here.

And if you would like personalised support to assess the broader drivers contributing to recurrence, you can learn more about working with me here.